CEL-SCI Corporation
General ticker "CVM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.7M (TTM average)
CEL-SCI Corporation does not follow the US Stock Market performance with the rate: -7.6%.
Estimated limits based on current volatility of 4.2%: low 1.39$, high 1.51$
Factors to consider:
- Total employees count: 17381 as of 1995
- Top business risk factors: Substantial doubt about continuing as a going concern, Regulatory and compliance, High development costs, Product liability, Equity dilution
- Current price 66.5% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [4.41$, 16.01$]
- 2026-09-30 to 2027-09-30 estimated range: [2.89$, 11.00$]
Financial Metrics affecting the CVM estimates:
- Negative: with PPE of -0.9 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of -0.11 > -0.60
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
Short-term CVM quotes
Long-term CVM plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $31.48MM | $26.35MM | $24.81MM |
| Operating Income | $-31.48MM | $-26.35MM | $-24.81MM |
| Non-Operating Income | $-0.50MM | $-0.57MM | $-0.60MM |
| Interest Expense | $0.68MM | $0.75MM | $0.65MM |
| R&D Expense | $22.47MM | $18.16MM | $15.89MM |
| Income(Loss) | $-31.98MM | $-26.92MM | $-25.41MM |
| Net Income(Loss)* | $-31.98MM | $-26.92MM | $25,360.23MM |
| Stockholders Equity | $13.21MM | $12.87MM | $15.96MM |
| Inventory | $2.25MM | $1.02MM | $0.30MM |
| Assets | $30.53MM | $26.99MM | $28.16MM |
| Operating Cash Flow | $-22.85MM | $-18.81MM | $-17.12MM |
| Capital expenditure | $0.37MM | $0.09MM | $38.11MM |
| Investing Cash Flow | $-0.37MM | $-0.11MM | $-0.04MM |
| Financing Cash Flow | $4.69MM | $19.51MM | $23.37MM |
| Earnings Per Share** | $-21.57 | $-13.54 | $6,252.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.